Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Specials
Spring Home & Garden Show
Home & Realty
Outdoor Guide
Women
Fall Home Improvement
Spring Wellness
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
2024 Auction
2024 Readersâ Choice Awards
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Replimune Group Inc
(NQ:
REPL
)
6.420
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Apr 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
1,157,283
Open
6.470
Bid (Size)
5.800 (1)
Ask (Size)
6.410 (2)
Prev. Close
6.420
Today's Range
6.385 - 6.770
52wk Range
5.890 - 24.81
Shares Outstanding
46,772,263
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Replimune Group: Q3 Earnings Insights
February 08, 2024
Via
Benzinga
Barclays Maintains Overweight Rating for Replimune Group: Here's What You Need To Know
December 06, 2023
Via
Benzinga
Performance
YTD
-25.95%
-25.95%
1 Month
-20.25%
-20.25%
3 Month
-18.22%
-18.22%
6 Month
-52.95%
-52.95%
1 Year
-64.23%
-64.23%
More News
Read More
Crude Oil Moves Lower; AutoZone Profit Tops Views
December 05, 2023
Via
Benzinga
Topics
Stocks
Exposures
Fossil Fuels
US Equities
Why Daktronics Shares Are Trading Lower By Over 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
December 05, 2023
Via
Benzinga
The Latest Analyst Ratings for Replimune Group
August 01, 2023
Via
Benzinga
Analyst Ratings for Replimune Group
June 07, 2023
Via
Benzinga
Replimune Group Inc. (NASDAQ: REPL) Making Surprising Moves in Monday Session
June 05, 2023
Via
Investor Brand Network
12 Health Care Stocks Moving In Tuesday's Intraday Session
December 05, 2023
Via
Benzinga
Dow Falls 100 Points; ISM Services PMI Increases In November
December 05, 2023
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Why Is Replimune (REPL) Stock Down 48% Today?
December 05, 2023
Via
InvestorPlace
US Stocks Down; JM Smucker Posts Upbeat Earnings
December 05, 2023
Via
Benzinga
Topics
Stocks
Exposures
US Equities
What's Going On With Cancer-Focused Replimune Stock Today?
December 05, 2023
Via
Benzinga
Recap: Replimune Group Q4 Earnings
May 18, 2023
Via
Benzinga
Analyst Ratings for Replimune Group
December 07, 2022
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
December 05, 2023
Via
Benzinga
8 Health Care Stocks Whale Activity In Today's Session
November 07, 2023
Via
Benzinga
Replimune and Incyte Enter into Clinical Trial Collaboration and Supply Agreement to Evaluate RP1 and INCB99280 in Patients with Cutaneous Squamous Cell Carcinoma
July 31, 2023
From
Incyte
Via
Business Wire
Stock Market Rally Broadens Out; Apple Unveils Vision Pro, SEC Sues Binance, Coinbase: Weekly Review
June 09, 2023
Via
Investor's Business Daily
12 Health Care Stocks Moving In Monday's Intraday Session
June 05, 2023
Via
Benzinga
Why Amedisys Shares Are Trading Higher By 14%? Here Are Other Stocks Moving In Monday's Mid-Day Session
June 05, 2023
Via
Benzinga
ImmunoGen, Day One Surge On Cancer Drug Updates, But Arcus Crashes
June 05, 2023
Via
Investor's Business Daily
Top 5 Health Care Stocks Which Could Rescue Your Portfolio This Month
April 13, 2023
Via
Benzinga
Analyst Beefs Up Replimune Price Target As Recent Data Validates Treatment Platform
December 12, 2022
Via
Benzinga
PayPal To Rally Around 47%? Here Are 10 Other Price Target Changes For Monday
December 12, 2022
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For January 5, 2023
January 05, 2023
Via
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.